氟尿嘧啶-话题@MedSci

#氟尿嘧啶#

28篇内容 | 2139人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1542848, encodeId=76e415428483b, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=Lancet oncol：食管腺癌术前行新辅助化疗顺铂联合氟尿嘧啶与表柔比星、顺铂联合卡培他滨的疗效对比。, objectType=article, longId=107807, objectId=d5be10e807c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5be10e807c3, replyNumber=0, likeNumber=93, createdTime=2017-08-06, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5be10e807c3, moduleTitle=Lancet oncol：食管腺癌术前行新辅助化疗顺铂联合氟尿嘧啶与表柔比星、顺铂联合卡培他滨的疗效对比。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5be10e807c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542847, encodeId=8d07154284e27, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=Lancet Gastroen Heptaol：紫杉醇+氟尿嘧啶：有望成为转移性胰腺癌的一线治疗, objectType=article, longId=92859, objectId=f2839285956, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2839285956, replyNumber=0, likeNumber=53, createdTime=2017-03-23, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2839285956, moduleTitle=Lancet Gastroen Heptaol：紫杉醇+氟尿嘧啶：有望成为转移性胰腺癌的一线治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2839285956)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542846, encodeId=00121542846fa, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=JNCI：缺陷错配修复结肠癌III患者采用氟尿嘧啶联合奥沙利铂辅助化疗有效, objectType=article, longId=63038, objectId=409463038a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=409463038a2, replyNumber=0, likeNumber=77, createdTime=2016-02-06, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=409463038a2, moduleTitle=JNCI：缺陷错配修复结肠癌III患者采用氟尿嘧啶联合奥沙利铂辅助化疗有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=409463038a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542845, encodeId=ec5b154284536, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=Lancet：转移胰腺导管腺癌患者，Nanoliposomal irinotecan联合氟尿嘧啶和叶酸一起服用效果如何？, objectType=article, longId=59307, objectId=561e5930e4e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=561e5930e4e, replyNumber=0, likeNumber=57, createdTime=2015-11-24, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=561e5930e4e, moduleTitle=Lancet：转移胰腺导管腺癌患者，Nanoliposomal irinotecan联合氟尿嘧啶和叶酸一起服用效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=561e5930e4e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542844, encodeId=878b1542844c0, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=Lancet：氟尿嘧啶与提高乳腺癌无病存活率无关, objectType=article, longId=47836, objectId=d32a4e83697, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d32a4e83697, replyNumber=0, likeNumber=68, createdTime=2015-03-08, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d32a4e83697, moduleTitle=Lancet：氟尿嘧啶与提高乳腺癌无病存活率无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d32a4e83697)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542843, encodeId=3390154284365, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=CSMO 2014 ：David Kerr教授谈结直肠癌氟尿嘧啶化疗的敏感性标志物, objectType=article, longId=37511, objectId=7ee73e51182, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ee73e51182, replyNumber=0, likeNumber=0, createdTime=2014-07-09, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ee73e51182, moduleTitle=CSMO 2014 ：David Kerr教授谈结直肠癌氟尿嘧啶化疗的敏感性标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ee73e51182)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542842, encodeId=de32154284222, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=Lancet Oncol：直肠癌术前放疗后氟尿嘧啶辅助化疗无生存优势, objectType=article, longId=31713, objectId=ebca31e13e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebca31e13e5, replyNumber=0, likeNumber=73, createdTime=2014-03-12, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebca31e13e5, moduleTitle=Lancet Oncol：直肠癌术前放疗后氟尿嘧啶辅助化疗无生存优势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebca31e13e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542841, encodeId=14081542841fc, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=Gastroenterology:PI3K抑制剂和5-氟尿嘧啶有不同疗效的胃癌分子亚型, objectType=article, longId=23917, objectId=0ae62391e12, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ae62391e12, replyNumber=0, likeNumber=96, createdTime=2013-09-07, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ae62391e12, moduleTitle=Gastroenterology:PI3K抑制剂和5-氟尿嘧啶有不同疗效的胃癌分子亚型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ae62391e12)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542840, encodeId=af641542840b0, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=Lancet Oncol：丝裂霉素/氟尿嘧啶放化疗方案可有效治疗肛门鳞状细胞癌, objectType=article, longId=18393, objectId=03b118393af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03b118393af, replyNumber=0, likeNumber=67, createdTime=2013-05-09, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03b118393af, moduleTitle=Lancet Oncol：丝裂霉素/氟尿嘧啶放化疗方案可有效治疗肛门鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03b118393af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542839, encodeId=cb0e15428393b, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=Lancet Oncology:氟尿嘧啶+奥沙利铂综合疗法或提高晚期直肠癌完全缓解率, objectType=article, longId=7898, objectId=a214e89847, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a214e89847, replyNumber=0, likeNumber=75, createdTime=2012-07-18, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a214e89847, moduleTitle=Lancet Oncology:氟尿嘧啶+奥沙利铂综合疗法或提高晚期直肠癌完全缓解率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a214e89847)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542838, encodeId=7aaa1542838d2, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=比较奥沙利铂联合5-氟尿嘧啶/亚叶酸钙（FOLFOX4方案）或阿霉素治疗国人晚期肝细胞癌的有效性和安全性的Ⅲ期临床研究, objectType=article, longId=2152, objectId=eeb3215275, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eeb3215275, replyNumber=0, likeNumber=60, createdTime=2010-09-21, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eeb3215275, moduleTitle=比较奥沙利铂联合5-氟尿嘧啶/亚叶酸钙（FOLFOX4方案）或阿霉素治疗国人晚期肝细胞癌的有效性和安全性的Ⅲ期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eeb3215275)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

氟尿嘧啶

2020-05-29

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

Lancet oncol：食管腺癌术前行新辅助化疗顺铂联合氟尿嘧啶与表柔比星、顺铂联合卡培他滨的疗效对比。

2017-08-06

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

Lancet Gastroen Heptaol：紫杉醇+氟尿嘧啶：有望成为转移性胰腺癌的一线治疗

2017-03-23

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

JNCI：缺陷错配修复结肠癌III患者采用氟尿嘧啶联合奥沙利铂辅助化疗有效

2016-02-06

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

Lancet：转移胰腺导管腺癌患者，Nanoliposomal irinotecan联合氟尿嘧啶和叶酸一起服用效果如何？

2015-11-24

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

Lancet：氟尿嘧啶与提高乳腺癌无病存活率无关

2015-03-08

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

CSMO 2014 ：David Kerr教授谈结直肠癌氟尿嘧啶化疗的敏感性标志物

2014-07-09

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

Lancet Oncol：直肠癌术前放疗后氟尿嘧啶辅助化疗无生存优势

2014-03-12

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

Gastroenterology:PI3K抑制剂和5-氟尿嘧啶有不同疗效的胃癌分子亚型

2013-09-07

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

Lancet Oncol：丝裂霉素/氟尿嘧啶放化疗方案可有效治疗肛门鳞状细胞癌

2013-05-09

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

Lancet Oncology:氟尿嘧啶+奥沙利铂综合疗法或提高晚期直肠癌完全缓解率

2012-07-18

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

比较奥沙利铂联合5-氟尿嘧啶/亚叶酸钙（FOLFOX4方案）或阿霉素治疗国人晚期肝细胞癌的有效性和安全性的Ⅲ期临床研究

2010-09-21

科室
- - 订阅+
  - 更多科室
工具
服务